Skip to main content
Faculty Research Labs

Peltier Lab

Dan Peltier looking through a microscope in his lab Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for high-risk malignant and nonmalignant hematologic disorders. Donor allo-T cells drive the curative graft-versus-tumor (GVT) effect; however, allo-Tcells also cause acute graft-versus-host disease (aGVHD), which remains a major complication of allo-HSCT. Long noncoding RNAs (lncRNAs) control gene expression with tissue specificity and fine-tune immune responses, but their role in alloimmune T cell responses is largely undefined. Using well-annotated clinical HSCT samples, lncRNA regulators of allogeneic T cells were identified. However, the molecular mechanisms and in vivo functions of these lncRNAs are unknown. The Peltier Lab uses murine allogeneic and xenogeneic models of aGVHD to determine the in vivo functions of these lncRNAs. Molecular mechanisms are explored both in vivo and in vitro using a variety of techniques.

Dan Peltier in his lab LncRNA molecular mechanisms are diverse and include coding for previously unrecognized functional microproteins. The role of lncRNA-encoded microproteins in T cell-intrinsic function has not been described. The Peltier Lab uses allogeneic and xenogeneic murine models of aGVHD, to determine the in vivo function of recently discovered microproteins encoded by lncRNA genes. The molecular mechanisms of these microproteins are determined using cutting-edge techniques including RNA sequencing and assessment of chromatin accessibility at the single cell level.

Overall, the Peltier Lab seeks to unlock the role of lncRNAs and unrecognized microproteins encoded by lncRNAs in alloimmunity. The tissue- and context-specificity of lncRNAs may make them ideal candidates for new diagnostic tests or targets of new medicines that may lead to improved outcomes following allogeneic HSCT. By exploring the uncharted role of lncRNAs and microproteins in T cell biology, these studies may also reveal new insights for other T cell-mediated disorders.

The Peltier Lab is located within the Hematologic Malignancies and Stem Cell Biology research group at the Herman B Wells Center for Pediatric Research.

Research Funding

Amy Strelzer Manasevit Research Program Award funded through Be The Match Foundation®

NHLBI K08 (in transition)

Publications

A full list of publications by Dan Peltier, MD, PhD, are available on PubMed.

Sun Y, Dotson G, Muir L, Ronquist S, Oravecz-Wilson K, Peltier D, Seike K, Li L, Meixner W, Rajapakse I, Reddy P: Rearrangement of T Cell Genome Architecture Regulates GVHD. iScience. 2022 Sep; 25(9).


Peltier D, Butterbaugh A, Reddy P: Linc'ing RNA to Immunity. Trends in Immunology. 2022 Jun;43(6):478-495.

Magenau JM, Peltier DC, Riwes M, Pawarode A, Parkin B, Braun TM, Anand S, Ghosh M, Maciejewski J, Yanik GA, Choi SW, Talpaz M, Reddy P: Type-1 Interferon to Prevent Leukemia Relapse after Allogeneic Transplantation. Blood Adv: 2021. PM34607341


Fujiwara H, Seike K, Brooks MD, Mathew AV, Kovalenko I, Pal A, Lee HJ, Peltier D, Kim S, Liu C, Oravecz-Wilson K, Li L, Sun Y, Byun J, Maeda Y, Wicha MS, Saunders TL, Rehemtulla A, Lyssiotis CA, Pennathur S, Reddy P: Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology. Nat Immunol 22(11): 1440-1451, 2021. PM34686860


Peltier D, Radosevich M, Ravikumar V, Pitchiaya S, Decoville T, Wood SC, Hou G, Zajac C, Oravecz- Wilson K, Sokol D, Henig I, Wu J, Kim S, Taylor A, Fujiwara H, Sun Y, Rao A, Chinnaiyan AM, Goldstein DR, Reddy P: RNA-seq of human T cells after hematopoietic stem cell transplantation identifies Linc00402 as a regulator of T cell alloimmunity. Sci Transl Med 13(585): eaaz0316, 2021. PM33731431

Toubai T, Fujiwara H, Rossi C, Riwes M, Tamaki H, Zajac C, Liu C, Mathew AV, Byun J, Oravecz-Wilson K, Matsuda I, Sun Y, Peltier D, Wu J, Chen J, Seregin S, Henig I, Kim S, Brabbs S, Pennathur S, Chen G, Reddy P: Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition. Nat Microbiol 4: 800–812, 2019. PM30858572

Toubai T, Tamaki H, Peltier DC, Rossi C, Oravecz-Wilson K, Liu C, Zajac C, Wu J, Sun Y, Fujiwara H, Henig I, Kim S, Lombard DB, Reddy P: Mitochondrial Deacetylase SIRT3 Plays an Important Role in Donor T Cell Responses after Experimental Allogeneic Hematopoietic Transplantation. J Immunol 201 (11): 3443-3455, 2018. PM30389773/PMC6240608

Fujiwara H, Docampo MD, Riwes M, Peltier D, Toubai T, Henig I, Wu SJ, Kim S, Taylor A, Brabbs S, Liu C, Zajac C, Oravecz-Wilson K, Sun Y, Núñez G, Levine JE, van den Brink MRM, Ferrara JLM, Reddy P: Microbial metabolite sensor GPR43 controls severity of experimental GVHD. Nat Commun 9(1): 3674, 2018. PM30201970/PMC6131147

Peltier D, Reddy P: Non-Coding RNA Mediated Regulation of Allogeneic T Cell Responses After Hematopoietic Transplantation. Front Immunol 9: 1110, 2018. PM29963039/PMC6013767

Magenau JM, Goldstein SC, Peltier D, Soiffer RJ, Braun T, Pawarode A, Riwes MM, Kennel M, Antin JH, Cutler CS, Ho VT, Alyea EP 3rd, Parkin BL, Yanik GA, Choi SW, Lewis EC, Dinarello CA, Koreth J, Reddy P: α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease. Blood 131(12): 1372-1379, 2018. PM29437593/PMC5865235

Research Team

61995-Peltier, Dan

Dan Peltier, MD, PhD

Assistant Professor of Pediatrics

Read Bio

Hridya Divakaran, Research Associate

Van Anh Do Thi, PhD, Postdoctoral Fellow